Made possible by a charitable contribution from Bayer
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.

Greetings!

We hope that you’re doing well and enjoying some cooler weather with the autumn season. In addition to the following updates and information that may be of interest to you, prostate cancer news article titles are listed below along with a link to the Us TOO web page that provides access to the full text for each article. 

We were pleased to present the Prostate Cancer Pathways for Patients and Caregivers event and webcast in Englewood, NJ, on Saturday, September 29. Medical experts presented a brief overview of men’s wellness and health risks, including prostate cancer, followed by educational content for managing prostate cancer that’s newly diagnosed, recurring, or advanced, in addition to a presentation on sexual health and intimacy. Video from the event will be posted within the next few weeks.

We’d like to thank all Pathways event attendees and sponsors, including local support group leaders, the online webcast audience, the team at Englewood Health who hosted the event, and presenters Dr. Anne Katz, Dr. Stacy Loeb, Dr. Charles G. Drake, Dr. Mazyar Ghanaat, Dr. Tracy Scheller, Mark Van Buren; and event sponsors Janssen Oncology, Bayer, Sanofi Genzyme, Astellas/Pfizer, Amgen, Genomic Health, AbbVie, and Augmenix. 

Please join us on Saturday, November 3, for the next Prostate Cancer Pathways for Patients and Caregivers event and webcast at NorthShore University HealthSystem in Skokie, IL. This free event will feature a special presentation from renowned expert and author Dr. Jeffrey Albaugh on the management of erectile dysfunction (ED) and incontinence related to prostate cancer treatment. REGISTER NOW to attend in person in Skokie or via webcast from anywhere with live audio and video. And get additional information on the new Us TOO web page on Sexual Heath & Intimacy and the new Us TOO web page on incontinence

Because prostate cancer can impact intimacy, it’s sometimes referred to as a “couple’s disease.” A woman may be subject to her own concerns in addition to those she shares with her husband/partner. A Forum for Her is a regular conference call series (and invitation-only Facebook group) from Us TOO which provides women with important peer-to-peer support. Calls are free and participants are not required to share their identity with the group. Get more information and join a call.

Change Together, an online resource managed by the Astellas Stakeholder Engagement team, will be presenting a prostate cancer advocacy webinar featuring leadership from ZERO, PHEN and Us TOO discussing advocacy initiatives that address the needs of the community. The event is tomorrow, Thursday, October 11, at 10:00 am Central Time. Register for the webinar and post-event access to the recorded content. 

Patient Power is hosting a webinar, "Tools for Living Well With Prostate Cancer," on Wednesday, October 24 at 3:00 pm Central Time featuring Dr. Maha Hussain along with Nurse Practitioner Brenda Martone from Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Register for the webinar and post-event access to the recorded content. 

In partnership with the National Alliance of State Prostate Cancer Coalitions (NASPCC), Cancer Care is offering a 15-week online support group for men currently receiving treatment for prostate cancer. Register or get more information.

Cancer Treatment Centers of America® (CTCA) is partnering with the NFL Alumni Association to spread the word about the importance of prostate cancer screening. From September 1, 2018, to October 15, 2018, eligible men ages 40 and older may sign up for free or discounted prostate-specific antigen (PSA) tests at LabCorp locations in the United States. Get more information.

The Medicare Open Enrollment period is from October 15 until December 7 each year. Access helpful information on MEDIGAP considerations and Medicare Advantage and Part D Prescription Drug Coverage.

CLINICAL TRIAL

The GALAHAD clinical research study from Janssen Research & Development is now enrolling men in the U.S. who have metastatic castration‐resistant prostate cancer and DNA‐repair anomalies to participate in a clinical trial of an oral investigational medication for prostate cancer. All participants will receive daily investigational medication. To learn more about the GALAHAD study and find out if you may be eligible, please visit: www.clinicaltrials.gov Study Identifier: NCT02854436

NEWS YOU CAN USE ARTICLES:

Please note that the content below lists only the title of the article rather than a direct link to the content. For access to the full article CLICK HERE .

  • National Prostate Health Month: Dr. David Samadi Comments on Raised Risk of Suicide for Men Diagnosed with Prostate Cancer

  • Researchers identify pitfall in popular prostate cancer PET imaging method

  • Recent Findings from University of Bologna Provide New Insights into Prostate Cancer (State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer)

  • New genetic compound marker could help early diagnosis of aggressive prostate cancer

  • Studies from Cancer Institute in the Area of Prostate Cancer Reported (The evolving landscape of metastatic hormone-sensitive prostate cancer: a...

  • New Prostate Cancer Findings from Walden University Described (Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as...

  • New Prostate Cancer Findings Reported from Netherlands Comprehensive Cancer Organisation (Values and preferences of men for undergoing...

  • Studies from Boston Children's Hospital in the Area of Prostate Cancer Described (Approaches to the discovery of non-invasive urinary biomarkers of...

  • Health-Related Quality of Life Maintained with Addition of ERLEADA® to Androgen Deprivation Therapy for Patients with Non-Metastatic...

  • New Findings from Johns Hopkins University Describe Advances in Prostate Cancer (The microbiome in prostate inflammation and prostate cancer)

  • UTHSC Professor Receives DOD Prostate Cancer Research Grant

  • Prostate cancer survivor Kwame Raoul campaigns for Illinois AG with a health message

  • Nanoparticle therapeutic restores function of tumor suppressor in prostate cancer

  • US Department of Defense funds UIC research on prostate cancer

  • The Prostate Cancer Foundation Reveals The First National Report About Lack Of Basic Prostate Cancer Understanding In The U.S.

  • New Findings in Brachytherapy Described by J.W. Sanders and Co-Researchers (Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy)


Take care and let us know how we can help provide you with educational resources, support services and personal connections to others in the prostate cancer community.


All the best,




Chuck Strand, Chief Executive Officer
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Manager
Amy Woods, Director of Development